+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific ePharmacy Market By Drug Type (Over-the-Counter Products and Prescription Medicines), By Country, Growth Potential, Industry Analysis Report and Forecast, 2021 - 2027

  • PDF Icon

    Report

  • 70 Pages
  • September 2021
  • Region: Asia Pacific
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5472806

The Asia Pacific ePharmacy Market is expected to witness market growth of 17.8% CAGR during the forecast period (2021-2027).

The priorities of health systems have changed over the time since the outset of the COVID-19 pandemic. In addition, the pandemic compelled emerging nations to increase their focus on the priorities of infrastructure in non-rural centers. The pandemic emerged as a major challenge for various nations. Additionally, nations like India are focusing on taking strict actions to prevent the effects of COVID-19 and make it an opportunity to improve their healthcare infrastructure. Moreover, various government initiatives are aiming to improve and advance the healthcare system, hence, creating new growth opportunities for ePharmacy market.

The ePharmacy market in the Asia-Pacific is expected to exhibit enormous growth in the forthcoming years. Nations like China and India are the major contributors for the ePharmacy market in the region. In addition, the Chinese government has been more involved in regulating the ePharmacy market.

Additionally, the ePharmacy market is at a developing stage in India as the number of customers is inclining towards purchasing medicines and health products through digital means. Also, ePharmacies are gradually gaining attention among customers as well as government. Moreover, around 250 ePharmacies have been set up in the nation in the past few years. Further, the demand for OTC medicines has increased in ePharmacy. Thus, these factors are anticipated to boost the growth of the regional market.

The China market dominated the Asia Pacific Over-the-Counter Products Market by Country in 2020, thereby, achieving a market value of $7,956.3 Million by 2027. The Japan market is exhibiting a CAGR of 18.3% during (2021 - 2027). Additionally, The India market is anticipated to witness a CAGR of 18.3% during (2021 - 2027).

Based on Drug Type, the market is segmented into Over-the-Counter Products and Prescription Medicines. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.



The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include The Kroger Co., Walgreen Co., Giant Eagle, Inc., Walmart, Inc., Express Scripts Holding Company (Cigna), CVS Health (CVS Pharmacy, Inc.), Optum Rx, Inc. (United Health Group), Rowlands Pharmacy (the PHOENIX group), DocMorris (Zur Rose Group AG), and Amazon Pharmacy (Amazon.com).



Scope of the Study


Market Segments Covered in the Report:


By Drug Type

  • Over-the-Counter Products
  • Prescription Medicines

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Key Market Players


List of Companies Profiled in the Report:


  • The Kroger Co.
  • Walgreen Co.
  • Giant Eagle, Inc.
  • Walmart, Inc.
  • Express Scripts Holding Company (Cigna)
  • CVS Health (CVS Pharmacy, Inc.)
  • Optum Rx, Inc. (United Health Group)
  • Rowlands Pharmacy (the PHOENIX group)
  • DocMorris (Zur Rose Group AG)
  • Amazon Pharmacy (Amazon.com)

Unique Offerings from the Publisher

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific ePharmacy Market, by Drug Type
1.4.2 Asia Pacific ePharmacy Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 COVID-19 impact
2.1.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2017, Jun - 2021, Jun) Leading Players
Chapter 4. Asia Pacific ePharmacy Market by Drug Type
4.1 Asia Pacific Over-the-Counter Products Market by Country
4.2 Asia Pacific Prescription Medicines Market by Country
Chapter 5. Asia Pacific ePharmacy Market by Country
5.1 China ePharmacy Market
5.1.1 China ePharmacy Market by Drug Type
5.2 Japan ePharmacy Market
5.2.1 Japan ePharmacy Market by Drug Type
5.3 India ePharmacy Market
5.3.1 India ePharmacy Market by Drug Type
5.4 South Korea ePharmacy Market
5.4.1 South Korea ePharmacy Market by Drug Type
5.5 Singapore ePharmacy Market
5.5.1 Singapore ePharmacy Market by Drug Type
5.6 Malaysia ePharmacy Market
5.6.1 Malaysia ePharmacy Market by Drug Type
5.7 Rest of Asia Pacific ePharmacy Market
5.7.1 Rest of Asia Pacific ePharmacy Market by Drug Type
Chapter 6. Company Profiles
6.1 The Kroger Co.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Recent strategies and developments:
6.1.3.1 Partnerships, Collaborations, and Agreements:
6.1.3.2 Geographical Expansions:
6.2 Walgreens Boots Alliance, Inc. (Walgreen Co.)
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Recent strategies and developments:
6.2.4.1 Partnerships, Collaborations, and Agreements:
6.2.4.2 Acquisition and Mergers:
6.3 Express Scripts Holding Company (Cigna)
6.3.1 Company Overview
6.3.2 Recent strategies and developments:
6.3.2.1 Partnerships, Collaborations, and Agreements:
6.3.2.2 Product Launches and Product Expansions:
6.4 Giant Eagle, Inc.
6.4.1 Company Overview
6.4.2 Recent strategies and developments:
6.4.2.1 Partnerships, Collaborations, and Agreements:
6.4.2.2 Product Launches and Product Expansions:
6.5 Rowlands Pharmacy (the PHOENIX group)
6.5.1 Company Overview
6.5.2 Recent strategies and developments:
6.5.2.1 Acquisition and Mergers:
6.6 CVS Health Corporation (CVS Pharmacy, Inc.)
6.7 UnitedHealth Group, Inc. (Optum, Inc.)
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental Analysis
6.7.4 Recent strategies and developments:
6.7.4.1 Partnerships, Collaborations, and Agreements:
6.7.4.2 Geographical Expansions:
6.8 Amazon.com, Inc. (Amazon Pharmacy)
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Recent strategies and developments:
6.8.4.1 Product Launches and Product Expansions:
6.8.4.2 Acquisition and Mergers:
6.8.5 SWOT Analysis
6.10. DocMorris N.V.
6.10.1 Company Overview
6.10.2 Recent strategies and developments:
6.10.2.1 Partnerships, Collaborations, and Agreements:
6.10.2.2 Product Launches and Product Expansions:
6.10.2.3 Acquisition and Mergers:

Companies Mentioned

  • The Kroger Co.
  • Walgreen Co.
  • Giant Eagle, Inc.
  • Walmart, Inc.
  • Express Scripts Holding Company (Cigna)
  • CVS Health (CVS Pharmacy, Inc.)
  • Optum Rx, Inc. (United Health Group)
  • Rowlands Pharmacy (the PHOENIX group)
  • DocMorris (Zur Rose Group AG)
  • Amazon Pharmacy (Amazon.com)

Methodology

Loading
LOADING...